Profile
CNTG DHR-PB TMO DHR IQV A
Company Name Centogene N.V. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $9.43M $916.76B $209.20B $175.69B $39.38B $38.46B
Employees 0.38K 79.00K 122.00K 61.00K 88.00K 17.40K
CEO Ms. Kim Stratton Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
CNTG DHR-PB TMO DHR IQV A
Quant Rating Score 1 5 3 3 3 3
Quant Rating Strong Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
CNTG DHR-PB TMO DHR IQV A
Last Close $0.325 $1261.26 $546.92 $243.25 $216.99 $133.86
High 52 $1.25 $1261.26 $624.21 $280.76 $259.1 $154.64
Low 52 $0.29 $1261.26 $528.82 $224.58 $205.82 $125.42
Price vs. 52 Week High -74 % 0 % -12.38 % -13.36 % -16.25 % -13.44 %
Price vs. 52 Week Low 12.07 % 0 % 3.42 % 8.31 % 5.43 % 6.73 %
Total Return
CNTG DHR-PB TMO DHR IQV A
1 Month Return 0 % 0 % -8.38 % -10.02 % -5.35 % -6.93 %
3 Month Return 0 % 0 % -8.71 % -8.96 % -6.25 % -1.28 %
6 Month Return -16.67 % 0 % -7.78 % -4 % -7.3 % -10.62 %
9 Month Return -66.32 % 0 % 0.01 % -1.45 % -0.41 % 1.17 %
YTD Return -72.92 % 0 % 3.04 % 5.15 % -6.22 % -3.72 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CNTG DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.43 % 0.28 % 0.43 % - 0.71 %
Dividend Paid and Capex Coverage Ration (TTM) -793.73 % 3.16 % 9.33 % 3.07 % 4.18 % 2.79 %
Dividend Per Share (TTM) - 1.05 % 1.52 % 1.05 % - 0.94 %
Payout Ratio (TTM) - 17.87 % 9.29 % 19.86 % - 19.25 %
Growth
CNTG DHR-PB TMO DHR IQV A
Asset Growth -16.8 % 0.16 % 1.62 % 0.16 % 5.3 % 2.19 %
Gross Profit Growth -41.25 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth 0.14 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year -72.51 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year -17.17 % 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year 21.17 % 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth -4.94 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth 10.08 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share -20.87 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share -116.48 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share -358.01 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth -4.94 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) -39.54 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG -424.31 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG -469.52 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG -1975.33 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth 13.89 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth 13.89 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -425.04 % 5.13 % 7.75 % 5.13 % 8.21 % 12.05 %
Share Holder 3 Year Equity Growth Per Share -128.6 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -165.41 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share -694.42 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - -1.19 % 16.73 % -1.19 % - 7.8 %
Dividend 3 Year Growth Per Share - 28 % 59.21 % 28 % - 25.46 %
Dividend 5 Year Growth Per Share - 80.2 % 104.77 % 80.2 % - 51.49 %
Dividend 10 Year Growth Per Share - 1389.16 % 125.8 % 1389.16 % - 97.03 %
Debt Growth 33.74 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth -37.13 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
CNTG DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 36.13 % 58.45 % 41.24 % 59.61 % 29.83 % 54.86 %
Return on Assets TTM -31.7 % 5.33 % 6.11 % 4.83 % 5.17 % 12.85 %
Return on Equity TTM 120.76 % 8.42 % 13.01 % 7.48 % 21.5 % 23.4 %
Return on Capital Employed TTM -62.9 % 7.39 % 8.36 % 5.43 % 10.8 % 17.47 %
Net Income Per EBT TTM 100.05 % 83.98 % 89.76 % 102.75 % 93.79 % 91.75 %
EBT Per Ebit TTM 115.01 % 94.74 % 95.34 % 95.2 % 68.68 % 102.39 %
EBIT Per Revenue TTM -86.31 % 21.3 % 16.92 % 19.87 % 14.2 % 23.15 %
Cash Flow To Debt Ratio TTM -39.52 % 36.11 % 25.77 % 35.88 % 19.08 % 60.91 %
Receivables Turnover TTM 1.27 7.76 5.13 5.71 4.73 5.3
Payables Turnover TTM 2.79 6.49 9.55 5.07 3.14 5.9
Inventory Turnover TTM 6.39 4.12 4.58 3.02 55.27 3
Fixed Asset Turnover TTM 127.74 % 463.28 % 450.17 % 413.59 % 1989.51 % 449.31 %
Asset Turnover TTM 31.91 % 31.45 % 42.22 % 24.85 % 56.51 % 59.09 %
Operating Cash Flow Per Share TTM -1.14 9.27 23.82 8.7 14.16 6.16
Free Cash Flow Per Share TTM -1.14 7.39 22.76 6.93 10.77 4.89
Cash Per Share TTM 65.4 % 937.04 % 1739.53 % 363.35 % 940.14 % 613.45 %
Operating Cash Flow Sales Ratio TTM -128.94 % 26.52 % 21.48 % 31.39 % 16.78 % 27.49 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.13 % 79.76 % 95.55 % 79.68 % 76.07 % 79.34 %
Cash Flow Coverage Ratios TTM -39.52 % 36.11 % 25.77 % 35.88 % 19.08 % 60.91 %
Price To Free Cash Flows Ratio TTM -0.28 31.67 24.06 35.07 20.08 27.14
Price To Operating Cash Flows Ratio TTM -0.27 26.24 22.96 27.97 15.33 21.74
Price Cash Flow Ratio TTM -0.27 26.24 22.96 27.97 15.33 21.74
Income Statement (TTM)
CNTG DHR-PB TMO DHR IQV A
Revenue $0.05B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $0.01B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 24.42% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.03B $7.55B $10.8B $7.55B $3.21B $1.68B
Net Income $-0.03B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -1.24 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
CNTG DHR-PB TMO DHR IQV A
Long Term Debt $0.05B $17.66B $31.31B $17.66B $12.96B $2.85B
Total Liabilities $0.1B $31B $51.88B $31B $20.57B $4.92B
Total Equity $-0.03B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0.08B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.08B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
CNTG DHR-PB TMO DHR IQV A
Net Income $-0.03B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $-0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-0.82B $-0.52B $-0.82B $0B $-0.27B
Operating Cash Flow $-0.04B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 133.7
ACRS Aclaris Therapeutics, Inc. 2.5416
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.1864
AWH Aspira Women's Health Inc. 0.8201
BDSX Biodesix, Inc. 1.395
BIAF bioAffinity Technologies, Inc. 1.28
BIAFW bioAffinity Technologies, Inc. 0.9495
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.2648
BNR Burning Rock Biotech Limited 3.64
CDNA CareDx, Inc 23.21
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.8618
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 216.07
CSTL Castle Biosciences, Inc. 32.77
DGX Quest Diagnostics Incorporated 161.78
DHR Danaher Corporation 239.42
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to CNTG
Ticker ETF Name Weight Percentage Price
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.15 72.5283
Unlock